Machado Y, Oliveira M, Mundoca M, Viana B, de Miranda D, Romano-Silva M
Gen Psychiatr. 2024; 37(6):e101220.
PMID: 39737338
PMC: 11683908.
DOI: 10.1136/gpsych-2023-101220.
Wang J, Wei Y, Hu Q, Tang Y, Zhu H, Wang J
Schizophr Res Cogn. 2024; 39:100339.
PMID: 39687049
PMC: 11646743.
DOI: 10.1016/j.scog.2024.100339.
Ye S, Guan X, Xiu M, Wu F, Huang Y
Neurotherapeutics. 2024; 21(5):e00392.
PMID: 38944636
PMC: 11579878.
DOI: 10.1016/j.neurot.2024.e00392.
Mao J, Fan K, Zhang Y, Wen N, Fang X, Ye X
Heliyon. 2023; 9(9):e19912.
PMID: 37809845
PMC: 10559318.
DOI: 10.1016/j.heliyon.2023.e19912.
Du X, Li Z, Yuan N, Yin M, Zhao X, Lv X
World J Psychiatry. 2022; 12(9):1169-1182.
PMID: 36186505
PMC: 9521529.
DOI: 10.5498/wjp.v12.i9.1169.
The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis.
Lorentzen R, Nguyen T, McGirr A, Hieronymus F, Ostergaard S
Schizophrenia (Heidelb). 2022; 8(1):35.
PMID: 35853882
PMC: 9261093.
DOI: 10.1038/s41537-022-00248-6.
Assessment and Treatment of Negative Symptoms in Schizophrenia-A Regional Perspective.
Bitter I, Mohr P, Raspopova N, Szulc A, Samochowiec J, Micluia I
Front Psychiatry. 2022; 12:820801.
PMID: 35185643
PMC: 8855151.
DOI: 10.3389/fpsyt.2021.820801.
Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions.
Brandt S, Oral H, Arellano-Bravo C, Plawecki M, Hummer T, Francis M
Neurotherapeutics. 2021; 18(2):827-844.
PMID: 33844154
PMC: 8423934.
DOI: 10.1007/s13311-021-01046-1.
The safety and efficacy of adjunctive 20-Hz repetitive transcranial magnetic stimulation for treatment of negative symptoms in patients with schizophrenia: A double-blinded, randomized, sham-controlled study.
Singh S, Kumar N, Verma R, Nehra A
Indian J Psychiatry. 2020; 62(1):21-29.
PMID: 32001927
PMC: 6964461.
DOI: 10.4103/psychiatry.IndianJPsychiatry_361_19.
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial.
Zhuo K, Tang Y, Song Z, Wang Y, Wang J, Qian Z
Neuropsychiatr Dis Treat. 2019; 15:1141-1150.
PMID: 31190822
PMC: 6514121.
DOI: 10.2147/NDT.S196086.
Effects of High-Frequency Transcranial Magnetic Stimulation for Cognitive Deficit in Schizophrenia: A Meta-Analysis.
Jiang Y, Guo Z, Xing G, He L, Peng H, Du F
Front Psychiatry. 2019; 10:135.
PMID: 30984036
PMC: 6450172.
DOI: 10.3389/fpsyt.2019.00135.
Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review.
Wojtalik J, Eack S, Smith M, Keshavan M
J Soc Social Work Res. 2018; 9(2):223-260.
PMID: 30505392
PMC: 6258037.
DOI: 10.1086/697566.
Efficacy Towards Negative Symptoms and Safety of Repetitive Transcranial Magnetic Stimulation Treatment for Patients with Schizophrenia: A Systematic Review.
Wang J, Zhou Y, Gan H, Pang J, Li H, Wang J
Shanghai Arch Psychiatry. 2017; 29(2):61-76.
PMID: 28765677
PMC: 5518263.
DOI: 10.11919/j.issn.1002-0829.217024.
Neuromodulation Treatments for Schizophrenia.
Dokucu M
Curr Treat Options Psychiatry. 2017; 2(3):339-348.
PMID: 28713665
PMC: 5510479.
DOI: 10.1007/s40501-015-0055-4.
Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes.
Hasan A, Strube W, Palm U, Wobrock T
Schizophr Bull. 2016; 42 Suppl 1:S95-S109.
PMID: 27460623
PMC: 4960427.
DOI: 10.1093/schbul/sbv158.
Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date.
Cole J, Green Bernacki C, Helmer A, Pinninti N, OReardon J
Innov Clin Neurosci. 2015; 12(7-8):12-9.
PMID: 26351619
PMC: 4558786.
Transcranial magnetic stimulation (TMS) for schizophrenia.
Dougall N, Maayan N, Soares-Weiser K, McDermott L, McIntosh A
Cochrane Database Syst Rev. 2015; (8):CD006081.
PMID: 26289586
PMC: 9395125.
DOI: 10.1002/14651858.CD006081.pub2.
Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.
Shi C, Yu X, Cheung E, Shum D, Chan R
Psychiatry Res. 2014; 215(3):505-13.
PMID: 24411074
PMC: 4127383.
DOI: 10.1016/j.psychres.2013.12.019.
Changes in plasticity across the lifespan: cause of disease and target for intervention.
Oberman L, Pascual-Leone A
Prog Brain Res. 2013; 207:91-120.
PMID: 24309252
PMC: 4392917.
DOI: 10.1016/B978-0-444-63327-9.00016-3.
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?.
Demirtas-Tatlidede A, Vahabzadeh-Hagh A, Pascual-Leone A
Neuropharmacology. 2012; 64:566-78.
PMID: 22749945
PMC: 3725288.
DOI: 10.1016/j.neuropharm.2012.06.020.